Amid restructuring efforts, Bayer has addressed its need for a capital infusion in pharma under a deal
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Bayer secured three billion euros in equity from Apollo-managed funds. This deal involves its long-acting reversible…
With Bayer’s pharma sales growth lagging behind its crop science and consumer health divisions in the second quarter, analysts…
As China-developed assets gain more attention from biopharma dealmakers, some industry watchers want to cur | As China-developed…
Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,
While dealmaking and investment dollars may be flowing across biopharma once again, acute challenges tied to policy, pricing and…
Antibody-drug conjugates from Kelun-Biotech and Hansoh Pharma, respectively partnered with Merck & Co. and GSK, delivered…
